Page last updated: 2024-11-06

pirlindole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Pirlindole is an atypical antidepressant with anxiolytic effects. It acts as a 5-HT1A receptor agonist, inhibiting the reuptake of serotonin and norepinephrine. Its chemical synthesis involves multiple steps and is patented. Research on pirlindole explores its potential therapeutic benefits in treating depression and anxiety, as well as its effects on cognition and sleep. Its unique mechanism of action compared to other antidepressants makes it a promising candidate for further investigation.'

pirlindole: RN given refers to parent cpd; synonym pyrazidol refers to mono-HCl; structure in Negwer, 5th ed, #2812 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID68802
CHEMBL ID32350
CHEBI ID91755
SCHEMBL ID373564
MeSH IDM0054889

Synonyms (62)

Synonym
BPBIO1_001107
PRESTWICK2_000973
OPREA1_500719
BRD-A54490543-066-03-6
DIVK1C_003729
pirlindole
pyrazidol
CDS1_002689
CBDIVE_011381
PRESTWICK3_000973
OPREA1_238580
1h-pyrazino[3,2,1-jk]carbazole, 2,3,3a,4,5,6-hexahydro-8-methyl-
CHEMDIV1_018945
AB00513982
8-methyl-2,3,3a,4,5,6-hexahydro-1h-pyrazino[3,2,1-jk]carbazole
pirlindol
pirlindole [inn]
2,3,3a,4,5,6-hexahydro-8-methyl-1h-pyrazino(3,2,1-jk)carbazole
pirlindolum [inn-latin]
pirlindol [inn-spanish, french]
PRESTWICK0_000973
SPBIO_002916
PRESTWICK1_000973
BSPBIO_001005
NCGC00024749-02
STK332141
pirazidol
CHEMBL32350
D08392
pyrazidol (tn)
60762-57-4
pirlindole (inn)
2,3,3a,4,5,6-hexahydro-8-methyl-1h-pyrazino[3,2,1-jk]carbazole
HMS640N03
AKOS000541385
pirlindolum
unii-v39yph45fz
v39yph45fz ,
FT-0682686
gtpl6638
pirlindole [who-dd]
1h-pyrazino(3,2,1-jk)carbazole, 2,3,3a,4,5,6-hexahydro-8-methyl-
145165-49-7
pirlindole [mart.]
AKOS016038519
DTXSID8048230
SCHEMBL373564
2,3,3a,4,5,6-hexahydro-8-methyl-1h-pyrazino[3,2,1-j,k]carbazole
8-methyl-2,3,3a,4,5,6-hexahydro-1h-pyrazino[3,2,1-jk]carbazole #
1h-pyrazino[3,2,1-jk]carbazole, 8-methyl-2,3,3a,4,5,6-hexahydro-
IWVRVEIKCBFZNF-UHFFFAOYSA-N
DB09244
lsm-1636
CHEBI:91755
8-methyl-2,3,3a,4,5,6-hexahydro1h-pyrazino[3,2,1-jk]carbazole
Q4363248
12-methyl-1,4-diazatetracyclo[7.6.1.05,16.010,15]hexadeca-9(16),10(15),11,13-tetraene
MS-23282
pirlindole free base
bdbm50531838
CS-0019919
HY-100679

Research Excerpts

Overview

Pirlindole is a selective and reversible inhibitor of monoamine oxidase (MAO) subtype A. It is approved in some European and non-European countries for the treatment of depression. Nitropirlindol is a more potent inhibitor of cGMP-dependent phosphodiesterase.

ExcerptReferenceRelevance
"Pirlindole is a selective and reversible inhibitor of monoamine oxidase (MAO) subtype A (MAO-A) that is approved in some European and non-European countries for the treatment of depression."( Pirlindole in the treatment of depression and fibromyalgia syndrome.
Branco, JC; Cruz, MR; Filipe, A; Tomé, AM, 2011
)
2.53
"Nitropirlindole is a more potent inhibitor of cGMP-dependent phosphodiesterase (IC50 = 115 microM) competing with the substrate for the catalytic site (K(i) = 70 microM)."( [The effect of the antidepressant pyrazidol and its nitro analog on cGMP-dependent phosphodiesterase from the soluble fractions of the human cerebral cortex].
Belov, AA; Bobruskin, ID; Fedotova, OA; Medvedev, AE; Medvedeva, MV; Shvedov, VI, 1993
)
0.74
"Pirlindole is a tetracyclic compound that has been characterized as a potential antidepressant drug. "( Pirlindole: a selective reversible inhibitor of monoamine oxidase A. A review of its preclinical properties.
Bruhwyler, J; Géczy, J; Liégeois, JF, 1997
)
3.18

Effects

Pirlindole has a favourable tolerability profile, with no deleterious effect on cardiovascular dynamics. The drug has an absolute bioavailability of between 20 and 30% due to an extensive first-pass effect.

ExcerptReferenceRelevance
"Pirlindole has a favourable tolerability profile, with no deleterious effect on cardiovascular dynamics."( Pirlindole in the treatment of depression and fibromyalgia syndrome.
Branco, JC; Cruz, MR; Filipe, A; Tomé, AM, 2011
)
2.53
"Pirlindole has an absolute bioavailability of between 20 and 30% due to an extensive first-pass effect."( Pirlindole: a selective reversible inhibitor of monoamine oxidase A. A review of its preclinical properties.
Bruhwyler, J; Géczy, J; Liégeois, JF, 1997
)
2.46
"Pirlindole has a favourable tolerability profile, with no deleterious effect on cardiovascular dynamics."( Pirlindole in the treatment of depression and fibromyalgia syndrome.
Branco, JC; Cruz, MR; Filipe, A; Tomé, AM, 2011
)
2.53
"Pirlindole has an absolute bioavailability of between 20 and 30% due to an extensive first-pass effect."( Pirlindole: a selective reversible inhibitor of monoamine oxidase A. A review of its preclinical properties.
Bruhwyler, J; Géczy, J; Liégeois, JF, 1997
)
2.46

Pharmacokinetics

ExcerptReferenceRelevance
"In a double-blind placebo-controlled cross-over study the pharmacokinetic and pharmacodynamic properties of acutely and chronically administered prilindol--a new antidepressant possessing both catecholamine-uptake and MAO-inhibitory properties--were investigated in ten normal healthy volunteers."( On acute and chronic CNS effects of antidepressants in normals: neurophysiological, behavioral and pharmacokinetic studies with pirlindol.
Grünberger, J; Saletu, B, 1985
)
0.27
" Time-efficacy calculations showed the maximal pharmacodynamic effect of pirlindol in the 4th to 6th hour, of 75 mg imipramine in the 2nd hour, of 20 mg tranylcypromine in the 4th hour and of 150 mg nomifensine in the 6th hour."( [Classification and determination of the pharmacodynamics of a new tetracyclic antidepressive agent, pirlindol, using pharmaco-EEG and psychometry].
Grünberger, L; Linzmayer, L; Saletu, B; Stöhr, H; Wittek, R, 1983
)
0.27

Bioavailability

ExcerptReferenceRelevance
"1 mg/kg/min) and orally (10 mg/kg) to estimate the absolute bioavailability of the drug."( Determination of pirlindole in plasma and urine by high-performance liquid chromatography.
Gärtner, W; Ostrowski, J; Passing, H; Resag, K; Theumer, J, 1984
)
0.61
" Pirlindole has an absolute bioavailability of between 20 and 30% due to an extensive first-pass effect."( Pirlindole: a selective reversible inhibitor of monoamine oxidase A. A review of its preclinical properties.
Bruhwyler, J; Géczy, J; Liégeois, JF, 1997
)
2.65

Dosage Studied

ExcerptRelevanceReference
" Blood level determination, quantitative EEG recordings, psychometric analyses and evaluation of pulse, blood pressure and side effects were carried out at hrs 0, 1, 2, 4, 6, 8 after the administration of one single dosis of 75 mg and 300 mg pirlindol, after one week's and two week's chronic administration of 3 X 75 mg pirlindol, as well as after one additional superimposed dosage of 75 mg and 225 mg on days 8 and 15 of chronic treatment, respectively."( On acute and chronic CNS effects of antidepressants in normals: neurophysiological, behavioral and pharmacokinetic studies with pirlindol.
Grünberger, J; Saletu, B, 1985
)
0.27
" Its pharmaco-EEG profile, especially after higher dosage (150 and 225 mg), was characterized by a decrease in delta and theta activity, an increase in alpha activity and a delta and theta activity, an increase in alpha activity and a decrease in beta activity, as well as by an attenuation of the average frequency and frequency deviation and a trend towards an augmentation of the amplitude and amplitude variability."( [Classification and determination of the pharmacodynamics of a new tetracyclic antidepressive agent, pirlindol, using pharmaco-EEG and psychometry].
Grünberger, L; Linzmayer, L; Saletu, B; Stöhr, H; Wittek, R, 1983
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
carbazoles
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (49)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Cytochrome P450 1A1Homo sapiens (human)IC50 (µMol)36.00000.00791.24789.9000AID1624090
Cytochrome P450 1A2Homo sapiens (human)IC50 (µMol)36.00000.00011.774010.0000AID1624090
Cytochrome P450 2E1Homo sapiens (human)IC50 (µMol)36.00000.01401.68726.2000AID1624090
Cytochrome P450 3A4Homo sapiens (human)IC50 (µMol)36.00000.00011.753610.0000AID1624090
Cytochrome P450 2C8Homo sapiens (human)IC50 (µMol)36.00000.00081.88487.9000AID1624090
Cytochrome P450 2D6Homo sapiens (human)IC50 (µMol)36.00000.00002.015110.0000AID1624090
Cytochrome P450 2A6Homo sapiens (human)IC50 (µMol)36.00000.00443.889510.0000AID1624090
Cytochrome P450 2C9 Homo sapiens (human)IC50 (µMol)36.00000.00002.800510.0000AID1624090
Cytochrome P450 4B1Homo sapiens (human)IC50 (µMol)36.00006.20006.20006.2000AID1624090
Cytochrome P450 2B6Homo sapiens (human)IC50 (µMol)36.00000.00113.418610.0000AID1624090
Cytochrome P450 3A5Homo sapiens (human)IC50 (µMol)36.00000.00330.70736.2000AID1624090
Cytochrome P450 2A7Homo sapiens (human)IC50 (µMol)36.00006.20006.20006.2000AID1624090
Cytochrome P450 3A7Homo sapiens (human)IC50 (µMol)36.00000.01402.75806.2000AID1624090
Cytochrome P450 2F1Homo sapiens (human)IC50 (µMol)36.00006.20006.20006.2000AID1624090
Cytochrome P450 2C18Homo sapiens (human)IC50 (µMol)36.00006.20006.20006.2000AID1624090
Cytochrome P450 2C19Homo sapiens (human)IC50 (µMol)36.00000.00002.398310.0000AID1624090
Cytochrome P450 2J2Homo sapiens (human)IC50 (µMol)36.00000.01202.53129.4700AID1624090
Cytochrome P450 4F2Homo sapiens (human)IC50 (µMol)36.00001.60004.26676.2000AID1624090
Cytochrome P450 4F8Homo sapiens (human)IC50 (µMol)36.00006.20006.20006.2000AID1624090
Cytochrome P450 4A11Homo sapiens (human)IC50 (µMol)36.00006.20006.20006.2000AID1624090
Cytochrome P450 4F3Homo sapiens (human)IC50 (µMol)36.00006.20006.20006.2000AID1624090
Transcriptional enhancer factor TEF-3Homo sapiens (human)IC50 (µMol)36.00005.90005.90005.9000AID1624090
Cytochrome P450 1B1Homo sapiens (human)IC50 (µMol)36.00000.00130.86969.9000AID1624090
Cytochrome P450 2A13Homo sapiens (human)IC50 (µMol)36.00006.20006.20006.2000AID1624090
Cytochrome P450 4A22Homo sapiens (human)IC50 (µMol)36.00006.20006.20006.2000AID1624090
Vitamin D 25-hydroxylaseHomo sapiens (human)IC50 (µMol)36.00006.20006.20006.2000AID1624090
Cytochrome P450 2U1Homo sapiens (human)IC50 (µMol)36.00006.20006.20006.2000AID1624090
Cytochrome P450 2W1Homo sapiens (human)IC50 (µMol)36.00006.20006.20006.2000AID1624090
Cytochrome P450 2S1Homo sapiens (human)IC50 (µMol)36.00006.20006.20006.2000AID1624090
Cytochrome P450 3A43 Homo sapiens (human)IC50 (µMol)36.00000.01402.75806.2000AID1624090
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)EC50 (µMol)12.00000.01901.70547.0000AID71694
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)EC50 (µMol)12.00000.01901.70547.0000AID71694
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)EC50 (µMol)12.00000.01901.70547.0000AID71694
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)EC50 (µMol)12.00000.01901.73677.0000AID71694
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)EC50 (µMol)12.00000.01901.70547.0000AID71694
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)EC50 (µMol)12.00000.01901.70547.0000AID71694
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)EC50 (µMol)12.00000.01901.70547.0000AID71694
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)EC50 (µMol)12.00000.00011.46937.0000AID71694
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)EC50 (µMol)12.00000.01901.70547.0000AID71694
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)EC50 (µMol)12.00000.01901.70547.0000AID71694
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)EC50 (µMol)12.00000.01901.70547.0000AID71694
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)EC50 (µMol)12.00000.01902.149910.0000AID71694
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)EC50 (µMol)12.00000.01901.70547.0000AID71694
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)EC50 (µMol)12.00000.01901.73677.0000AID71694
GABA theta subunitRattus norvegicus (Norway rat)EC50 (µMol)12.00000.01901.70547.0000AID71694
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)EC50 (µMol)12.00000.01901.70547.0000AID71694
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (182)

Processvia Protein(s)Taxonomy
cellular response to organic cyclic compoundCytochrome P450 1A1Homo sapiens (human)
response to hypoxiaCytochrome P450 1A1Homo sapiens (human)
long-chain fatty acid metabolic processCytochrome P450 1A1Homo sapiens (human)
lipid hydroxylationCytochrome P450 1A1Homo sapiens (human)
fatty acid metabolic processCytochrome P450 1A1Homo sapiens (human)
steroid biosynthetic processCytochrome P450 1A1Homo sapiens (human)
porphyrin-containing compound metabolic processCytochrome P450 1A1Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 1A1Homo sapiens (human)
steroid metabolic processCytochrome P450 1A1Homo sapiens (human)
estrogen metabolic processCytochrome P450 1A1Homo sapiens (human)
amine metabolic processCytochrome P450 1A1Homo sapiens (human)
response to nematodeCytochrome P450 1A1Homo sapiens (human)
response to herbicideCytochrome P450 1A1Homo sapiens (human)
ethylene metabolic processCytochrome P450 1A1Homo sapiens (human)
coumarin metabolic processCytochrome P450 1A1Homo sapiens (human)
flavonoid metabolic processCytochrome P450 1A1Homo sapiens (human)
response to iron(III) ionCytochrome P450 1A1Homo sapiens (human)
insecticide metabolic processCytochrome P450 1A1Homo sapiens (human)
dibenzo-p-dioxin catabolic processCytochrome P450 1A1Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 1A1Homo sapiens (human)
response to foodCytochrome P450 1A1Homo sapiens (human)
response to lipopolysaccharideCytochrome P450 1A1Homo sapiens (human)
response to vitamin ACytochrome P450 1A1Homo sapiens (human)
response to immobilization stressCytochrome P450 1A1Homo sapiens (human)
vitamin D metabolic processCytochrome P450 1A1Homo sapiens (human)
retinol metabolic processCytochrome P450 1A1Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 1A1Homo sapiens (human)
9-cis-retinoic acid biosynthetic processCytochrome P450 1A1Homo sapiens (human)
camera-type eye developmentCytochrome P450 1A1Homo sapiens (human)
nitric oxide metabolic processCytochrome P450 1A1Homo sapiens (human)
response to arsenic-containing substanceCytochrome P450 1A1Homo sapiens (human)
digestive tract developmentCytochrome P450 1A1Homo sapiens (human)
tissue remodelingCytochrome P450 1A1Homo sapiens (human)
hydrogen peroxide biosynthetic processCytochrome P450 1A1Homo sapiens (human)
response to hyperoxiaCytochrome P450 1A1Homo sapiens (human)
maternal process involved in parturitionCytochrome P450 1A1Homo sapiens (human)
hepatocyte differentiationCytochrome P450 1A1Homo sapiens (human)
cellular response to copper ionCytochrome P450 1A1Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 1A1Homo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycleCytochrome P450 1A1Homo sapiens (human)
response to 3-methylcholanthreneCytochrome P450 1A1Homo sapiens (human)
steroid catabolic processCytochrome P450 1A2Homo sapiens (human)
porphyrin-containing compound metabolic processCytochrome P450 1A2Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 1A2Homo sapiens (human)
cholesterol metabolic processCytochrome P450 1A2Homo sapiens (human)
estrogen metabolic processCytochrome P450 1A2Homo sapiens (human)
toxin biosynthetic processCytochrome P450 1A2Homo sapiens (human)
post-embryonic developmentCytochrome P450 1A2Homo sapiens (human)
alkaloid metabolic processCytochrome P450 1A2Homo sapiens (human)
regulation of gene expressionCytochrome P450 1A2Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 1A2Homo sapiens (human)
dibenzo-p-dioxin metabolic processCytochrome P450 1A2Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 1A2Homo sapiens (human)
lung developmentCytochrome P450 1A2Homo sapiens (human)
methylationCytochrome P450 1A2Homo sapiens (human)
monocarboxylic acid metabolic processCytochrome P450 1A2Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 1A2Homo sapiens (human)
retinol metabolic processCytochrome P450 1A2Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 1A2Homo sapiens (human)
cellular respirationCytochrome P450 1A2Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 1A2Homo sapiens (human)
hydrogen peroxide biosynthetic processCytochrome P450 1A2Homo sapiens (human)
oxidative demethylationCytochrome P450 1A2Homo sapiens (human)
cellular response to cadmium ionCytochrome P450 1A2Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 1A2Homo sapiens (human)
long-chain fatty acid metabolic processCytochrome P450 2E1Homo sapiens (human)
lipid hydroxylationCytochrome P450 2E1Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2E1Homo sapiens (human)
steroid metabolic processCytochrome P450 2E1Homo sapiens (human)
response to bacteriumCytochrome P450 2E1Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 2E1Homo sapiens (human)
carbon tetrachloride metabolic processCytochrome P450 2E1Homo sapiens (human)
benzene metabolic processCytochrome P450 2E1Homo sapiens (human)
4-nitrophenol metabolic processCytochrome P450 2E1Homo sapiens (human)
halogenated hydrocarbon metabolic processCytochrome P450 2E1Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 2E1Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2E1Homo sapiens (human)
lipid hydroxylationCytochrome P450 3A4Homo sapiens (human)
lipid metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid catabolic processCytochrome P450 3A4Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid metabolic processCytochrome P450 3A4Homo sapiens (human)
cholesterol metabolic processCytochrome P450 3A4Homo sapiens (human)
androgen metabolic processCytochrome P450 3A4Homo sapiens (human)
estrogen metabolic processCytochrome P450 3A4Homo sapiens (human)
alkaloid catabolic processCytochrome P450 3A4Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 3A4Homo sapiens (human)
calcitriol biosynthetic process from calciolCytochrome P450 3A4Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D metabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D catabolic processCytochrome P450 3A4Homo sapiens (human)
retinol metabolic processCytochrome P450 3A4Homo sapiens (human)
retinoic acid metabolic processCytochrome P450 3A4Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 3A4Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 3A4Homo sapiens (human)
oxidative demethylationCytochrome P450 3A4Homo sapiens (human)
lipid hydroxylationCytochrome P450 2C8Homo sapiens (human)
organic acid metabolic processCytochrome P450 2C8Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2C8Homo sapiens (human)
steroid metabolic processCytochrome P450 2C8Homo sapiens (human)
estrogen metabolic processCytochrome P450 2C8Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2C8Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2C8Homo sapiens (human)
retinol metabolic processCytochrome P450 2C8Homo sapiens (human)
retinoic acid metabolic processCytochrome P450 2C8Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 2C8Homo sapiens (human)
icosanoid biosynthetic processCytochrome P450 2C8Homo sapiens (human)
oxidative demethylationCytochrome P450 2C8Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 2C8Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2D6Homo sapiens (human)
steroid metabolic processCytochrome P450 2D6Homo sapiens (human)
cholesterol metabolic processCytochrome P450 2D6Homo sapiens (human)
estrogen metabolic processCytochrome P450 2D6Homo sapiens (human)
coumarin metabolic processCytochrome P450 2D6Homo sapiens (human)
alkaloid metabolic processCytochrome P450 2D6Homo sapiens (human)
alkaloid catabolic processCytochrome P450 2D6Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 2D6Homo sapiens (human)
isoquinoline alkaloid metabolic processCytochrome P450 2D6Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2D6Homo sapiens (human)
retinol metabolic processCytochrome P450 2D6Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 2D6Homo sapiens (human)
negative regulation of bindingCytochrome P450 2D6Homo sapiens (human)
oxidative demethylationCytochrome P450 2D6Homo sapiens (human)
negative regulation of cellular organofluorine metabolic processCytochrome P450 2D6Homo sapiens (human)
arachidonic acid metabolic processCytochrome P450 2D6Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2A6Homo sapiens (human)
steroid metabolic processCytochrome P450 2A6Homo sapiens (human)
coumarin metabolic processCytochrome P450 2A6Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2A6Homo sapiens (human)
coumarin catabolic processCytochrome P450 2A6Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2A6Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2C9 Homo sapiens (human)
steroid metabolic processCytochrome P450 2C9 Homo sapiens (human)
cholesterol metabolic processCytochrome P450 2C9 Homo sapiens (human)
estrogen metabolic processCytochrome P450 2C9 Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 2C9 Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2C9 Homo sapiens (human)
urea metabolic processCytochrome P450 2C9 Homo sapiens (human)
monocarboxylic acid metabolic processCytochrome P450 2C9 Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2C9 Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 2C9 Homo sapiens (human)
amide metabolic processCytochrome P450 2C9 Homo sapiens (human)
icosanoid biosynthetic processCytochrome P450 2C9 Homo sapiens (human)
oxidative demethylationCytochrome P450 2C9 Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 2C9 Homo sapiens (human)
fatty acid metabolic processCytochrome P450 4B1Homo sapiens (human)
biphenyl metabolic processCytochrome P450 4B1Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2B6Homo sapiens (human)
steroid metabolic processCytochrome P450 2B6Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2B6Homo sapiens (human)
cellular ketone metabolic processCytochrome P450 2B6Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2B6Homo sapiens (human)
lipid hydroxylationCytochrome P450 3A5Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 3A5Homo sapiens (human)
steroid metabolic processCytochrome P450 3A5Homo sapiens (human)
estrogen metabolic processCytochrome P450 3A5Homo sapiens (human)
alkaloid catabolic processCytochrome P450 3A5Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 3A5Homo sapiens (human)
retinol metabolic processCytochrome P450 3A5Homo sapiens (human)
retinoic acid metabolic processCytochrome P450 3A5Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 3A5Homo sapiens (human)
oxidative demethylationCytochrome P450 3A5Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2A7Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2A7Homo sapiens (human)
coumarin metabolic processCytochrome P450 2A7Homo sapiens (human)
lipid hydroxylationCytochrome P450 3A7Homo sapiens (human)
steroid biosynthetic processCytochrome P450 3A7Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 3A7Homo sapiens (human)
steroid metabolic processCytochrome P450 3A7Homo sapiens (human)
estrogen metabolic processCytochrome P450 3A7Homo sapiens (human)
retinol metabolic processCytochrome P450 3A7Homo sapiens (human)
retinoic acid metabolic processCytochrome P450 3A7Homo sapiens (human)
oxidative demethylationCytochrome P450 3A7Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2F1Homo sapiens (human)
response to toxic substanceCytochrome P450 2F1Homo sapiens (human)
naphthalene catabolic processCytochrome P450 2F1Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2F1Homo sapiens (human)
positive regulation of cell growthTranscriptional enhancer factor TEF-1Homo sapiens (human)
hippo signalingTranscriptional enhancer factor TEF-1Homo sapiens (human)
positive regulation of DNA-templated transcriptionTranscriptional enhancer factor TEF-1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IITranscriptional enhancer factor TEF-1Homo sapiens (human)
protein-containing complex assemblyTranscriptional enhancer factor TEF-1Homo sapiens (human)
positive regulation of miRNA transcriptionTranscriptional enhancer factor TEF-1Homo sapiens (human)
embryonic organ developmentTranscriptional enhancer factor TEF-1Homo sapiens (human)
regulation of transcription by RNA polymerase IITranscriptional enhancer factor TEF-1Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2C18Homo sapiens (human)
retinol metabolic processCytochrome P450 2C18Homo sapiens (human)
retinoic acid metabolic processCytochrome P450 2C18Homo sapiens (human)
linoleic acid metabolic processCytochrome P450 2C18Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2C18Homo sapiens (human)
long-chain fatty acid metabolic processCytochrome P450 2C19Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2C19Homo sapiens (human)
steroid metabolic processCytochrome P450 2C19Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 2C19Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2C19Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2C19Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 2C19Homo sapiens (human)
fatty acid metabolic processCytochrome P450 2J2Homo sapiens (human)
icosanoid metabolic processCytochrome P450 2J2Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2J2Homo sapiens (human)
regulation of heart contractionCytochrome P450 2J2Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2J2Homo sapiens (human)
linoleic acid metabolic processCytochrome P450 2J2Homo sapiens (human)
organic acid metabolic processCytochrome P450 2J2Homo sapiens (human)
very long-chain fatty acid metabolic processCytochrome P450 4F2Homo sapiens (human)
long-chain fatty acid metabolic processCytochrome P450 4F2Homo sapiens (human)
renal water homeostasisCytochrome P450 4F2Homo sapiens (human)
pressure natriuresisCytochrome P450 4F2Homo sapiens (human)
icosanoid metabolic processCytochrome P450 4F2Homo sapiens (human)
leukotriene metabolic processCytochrome P450 4F2Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 4F2Homo sapiens (human)
blood coagulationCytochrome P450 4F2Homo sapiens (human)
regulation of blood pressureCytochrome P450 4F2Homo sapiens (human)
fatty acid omega-oxidationCytochrome P450 4F2Homo sapiens (human)
arachidonic acid metabolic processCytochrome P450 4F2Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 4F2Homo sapiens (human)
negative regulation of icosanoid secretionCytochrome P450 4F2Homo sapiens (human)
positive regulation of icosanoid secretionCytochrome P450 4F2Homo sapiens (human)
leukotriene B4 catabolic processCytochrome P450 4F2Homo sapiens (human)
vitamin E metabolic processCytochrome P450 4F2Homo sapiens (human)
menaquinone catabolic processCytochrome P450 4F2Homo sapiens (human)
phylloquinone catabolic processCytochrome P450 4F2Homo sapiens (human)
vitamin K catabolic processCytochrome P450 4F2Homo sapiens (human)
sodium ion homeostasisCytochrome P450 4F2Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 4F2Homo sapiens (human)
icosanoid metabolic processCytochrome P450 4F8Homo sapiens (human)
prostaglandin metabolic processCytochrome P450 4F8Homo sapiens (human)
long-chain fatty acid metabolic processCytochrome P450 4A11Homo sapiens (human)
renal water homeostasisCytochrome P450 4A11Homo sapiens (human)
pressure natriuresisCytochrome P450 4A11Homo sapiens (human)
fatty acid metabolic processCytochrome P450 4A11Homo sapiens (human)
leukotriene metabolic processCytochrome P450 4A11Homo sapiens (human)
arachidonic acid metabolic processCytochrome P450 4A11Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 4A11Homo sapiens (human)
oxylipin biosynthetic processCytochrome P450 4A11Homo sapiens (human)
positive regulation of icosanoid secretionCytochrome P450 4A11Homo sapiens (human)
leukotriene B4 catabolic processCytochrome P450 4A11Homo sapiens (human)
sodium ion homeostasisCytochrome P450 4A11Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 4A11Homo sapiens (human)
linoleic acid metabolic processCytochrome P450 4A11Homo sapiens (human)
kidney developmentCytochrome P450 4A11Homo sapiens (human)
lauric acid metabolic processCytochrome P450 4A11Homo sapiens (human)
icosanoid biosynthetic processCytochrome P450 4A11Homo sapiens (human)
icosanoid metabolic processCytochrome P450 4F3Homo sapiens (human)
leukotriene metabolic processCytochrome P450 4F3Homo sapiens (human)
arachidonic acid metabolic processCytochrome P450 4F3Homo sapiens (human)
leukotriene B4 catabolic processCytochrome P450 4F3Homo sapiens (human)
skeletal system developmentTranscriptional enhancer factor TEF-3Homo sapiens (human)
cell fate specificationTranscriptional enhancer factor TEF-3Homo sapiens (human)
trophectodermal cell fate commitmentTranscriptional enhancer factor TEF-3Homo sapiens (human)
DNA-templated transcriptionTranscriptional enhancer factor TEF-3Homo sapiens (human)
muscle organ developmentTranscriptional enhancer factor TEF-3Homo sapiens (human)
embryo implantationTranscriptional enhancer factor TEF-3Homo sapiens (human)
hippo signalingTranscriptional enhancer factor TEF-3Homo sapiens (human)
positive regulation of transcription by RNA polymerase IITranscriptional enhancer factor TEF-3Homo sapiens (human)
positive regulation of stem cell population maintenanceTranscriptional enhancer factor TEF-3Homo sapiens (human)
embryonic organ developmentTranscriptional enhancer factor TEF-3Homo sapiens (human)
regulation of transcription by RNA polymerase IITranscriptional enhancer factor TEF-3Homo sapiens (human)
vasculogenesisTranscriptional enhancer factor TEF-4Homo sapiens (human)
neural tube closureTranscriptional enhancer factor TEF-4Homo sapiens (human)
embryonic heart tube morphogenesisTranscriptional enhancer factor TEF-4Homo sapiens (human)
regulation of DNA-templated transcriptionTranscriptional enhancer factor TEF-4Homo sapiens (human)
transcription by RNA polymerase IITranscriptional enhancer factor TEF-4Homo sapiens (human)
notochord developmentTranscriptional enhancer factor TEF-4Homo sapiens (human)
hippo signalingTranscriptional enhancer factor TEF-4Homo sapiens (human)
positive regulation of DNA-templated transcriptionTranscriptional enhancer factor TEF-4Homo sapiens (human)
positive regulation of transcription by RNA polymerase IITranscriptional enhancer factor TEF-4Homo sapiens (human)
paraxial mesoderm developmentTranscriptional enhancer factor TEF-4Homo sapiens (human)
lateral mesoderm developmentTranscriptional enhancer factor TEF-4Homo sapiens (human)
protein-containing complex assemblyTranscriptional enhancer factor TEF-4Homo sapiens (human)
cellular response to retinoic acidTranscriptional enhancer factor TEF-4Homo sapiens (human)
regulation of stem cell differentiationTranscriptional enhancer factor TEF-4Homo sapiens (human)
embryonic organ developmentTranscriptional enhancer factor TEF-4Homo sapiens (human)
regulation of transcription by RNA polymerase IITranscriptional enhancer factor TEF-4Homo sapiens (human)
cellular response to organic cyclic compoundCytochrome P450 1B1Homo sapiens (human)
angiogenesisCytochrome P450 1B1Homo sapiens (human)
trabecular meshwork developmentCytochrome P450 1B1Homo sapiens (human)
DNA modificationCytochrome P450 1B1Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 1B1Homo sapiens (human)
nitric oxide biosynthetic processCytochrome P450 1B1Homo sapiens (human)
cell adhesionCytochrome P450 1B1Homo sapiens (human)
response to nutrientCytochrome P450 1B1Homo sapiens (human)
steroid metabolic processCytochrome P450 1B1Homo sapiens (human)
estrogen metabolic processCytochrome P450 1B1Homo sapiens (human)
negative regulation of cell population proliferationCytochrome P450 1B1Homo sapiens (human)
male gonad developmentCytochrome P450 1B1Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to oxidative stressCytochrome P450 1B1Homo sapiens (human)
toxin metabolic processCytochrome P450 1B1Homo sapiens (human)
positive regulation of vascular endothelial growth factor productionCytochrome P450 1B1Homo sapiens (human)
positive regulation of smooth muscle cell migrationCytochrome P450 1B1Homo sapiens (human)
sterol metabolic processCytochrome P450 1B1Homo sapiens (human)
arachidonic acid metabolic processCytochrome P450 1B1Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 1B1Homo sapiens (human)
collagen fibril organizationCytochrome P450 1B1Homo sapiens (human)
adrenal gland developmentCytochrome P450 1B1Homo sapiens (human)
negative regulation of cell migrationCytochrome P450 1B1Homo sapiens (human)
negative regulation of NF-kappaB transcription factor activityCytochrome P450 1B1Homo sapiens (human)
response to follicle-stimulating hormoneCytochrome P450 1B1Homo sapiens (human)
response to estradiolCytochrome P450 1B1Homo sapiens (human)
negative regulation of cell adhesion mediated by integrinCytochrome P450 1B1Homo sapiens (human)
benzene-containing compound metabolic processCytochrome P450 1B1Homo sapiens (human)
retinol metabolic processCytochrome P450 1B1Homo sapiens (human)
retinal metabolic processCytochrome P450 1B1Homo sapiens (human)
positive regulation of apoptotic processCytochrome P450 1B1Homo sapiens (human)
blood vessel endothelial cell migrationCytochrome P450 1B1Homo sapiens (human)
endothelial cell migrationCytochrome P450 1B1Homo sapiens (human)
estrous cycleCytochrome P450 1B1Homo sapiens (human)
positive regulation of translationCytochrome P450 1B1Homo sapiens (human)
positive regulation of angiogenesisCytochrome P450 1B1Homo sapiens (human)
positive regulation of receptor signaling pathway via JAK-STATCytochrome P450 1B1Homo sapiens (human)
membrane lipid catabolic processCytochrome P450 1B1Homo sapiens (human)
response to arsenic-containing substanceCytochrome P450 1B1Homo sapiens (human)
blood vessel morphogenesisCytochrome P450 1B1Homo sapiens (human)
retinal blood vessel morphogenesisCytochrome P450 1B1Homo sapiens (human)
ganglion developmentCytochrome P450 1B1Homo sapiens (human)
cellular response to hydrogen peroxideCytochrome P450 1B1Homo sapiens (human)
cellular response to cAMPCytochrome P450 1B1Homo sapiens (human)
cellular response to tumor necrosis factorCytochrome P450 1B1Homo sapiens (human)
cellular response to luteinizing hormone stimulusCytochrome P450 1B1Homo sapiens (human)
cellular response to cortisol stimulusCytochrome P450 1B1Homo sapiens (human)
cellular response to progesterone stimulusCytochrome P450 1B1Homo sapiens (human)
response to dexamethasoneCytochrome P450 1B1Homo sapiens (human)
endothelial cell-cell adhesionCytochrome P450 1B1Homo sapiens (human)
response to indole-3-methanolCytochrome P450 1B1Homo sapiens (human)
cellular response to toxic substanceCytochrome P450 1B1Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 1B1Homo sapiens (human)
response to 3-methylcholanthreneCytochrome P450 1B1Homo sapiens (human)
regulation of reactive oxygen species metabolic processCytochrome P450 1B1Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCytochrome P450 1B1Homo sapiens (human)
positive regulation of DNA biosynthetic processCytochrome P450 1B1Homo sapiens (human)
coumarin metabolic processCytochrome P450 2A13Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 2A13Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2A13Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2A13Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 4A22Homo sapiens (human)
lipid hydroxylationCytochrome P450 4A22Homo sapiens (human)
linoleic acid metabolic processCytochrome P450 4A22Homo sapiens (human)
lauric acid metabolic processCytochrome P450 4A22Homo sapiens (human)
arachidonic acid metabolic processCytochrome P450 4A22Homo sapiens (human)
kidney developmentCytochrome P450 4A22Homo sapiens (human)
icosanoid biosynthetic processCytochrome P450 4A22Homo sapiens (human)
vitamin metabolic processVitamin D 25-hydroxylaseHomo sapiens (human)
response to cesium ionVitamin D 25-hydroxylaseHomo sapiens (human)
response to ionizing radiationVitamin D 25-hydroxylaseHomo sapiens (human)
calcitriol biosynthetic process from calciolVitamin D 25-hydroxylaseHomo sapiens (human)
vitamin D metabolic processVitamin D 25-hydroxylaseHomo sapiens (human)
xenobiotic metabolic processVitamin D 25-hydroxylaseHomo sapiens (human)
organic acid metabolic processVitamin D 25-hydroxylaseHomo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 2U1Homo sapiens (human)
cytochrome metabolic processCytochrome P450 2U1Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2U1Homo sapiens (human)
organic acid metabolic processCytochrome P450 2U1Homo sapiens (human)
phospholipid metabolic processCytochrome P450 2W1Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2W1Homo sapiens (human)
retinoic acid catabolic processCytochrome P450 2W1Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 2W1Homo sapiens (human)
cytochrome metabolic processCytochrome P450 2W1Homo sapiens (human)
organic acid metabolic processCytochrome P450 2W1Homo sapiens (human)
icosanoid metabolic processCytochrome P450 2S1Homo sapiens (human)
prostaglandin metabolic processCytochrome P450 2S1Homo sapiens (human)
retinoic acid metabolic processCytochrome P450 2S1Homo sapiens (human)
cytochrome metabolic processCytochrome P450 2S1Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2S1Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2S1Homo sapiens (human)
female pregnancyTranscriptional enhancer factor TEF-5Homo sapiens (human)
hippo signalingTranscriptional enhancer factor TEF-5Homo sapiens (human)
positive regulation of transcription by RNA polymerase IITranscriptional enhancer factor TEF-5Homo sapiens (human)
asymmetric neuroblast divisionTranscriptional enhancer factor TEF-5Homo sapiens (human)
embryonic organ developmentTranscriptional enhancer factor TEF-5Homo sapiens (human)
regulation of transcription by RNA polymerase IITranscriptional enhancer factor TEF-5Homo sapiens (human)
cytochrome metabolic processCytochrome P450 3A43 Homo sapiens (human)
steroid metabolic processCytochrome P450 3A43 Homo sapiens (human)
oxidative demethylationCytochrome P450 3A43 Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (77)

Processvia Protein(s)Taxonomy
monooxygenase activityCytochrome P450 1A1Homo sapiens (human)
iron ion bindingCytochrome P450 1A1Homo sapiens (human)
protein bindingCytochrome P450 1A1Homo sapiens (human)
arachidonic acid monooxygenase activityCytochrome P450 1A1Homo sapiens (human)
oxidoreductase activityCytochrome P450 1A1Homo sapiens (human)
oxidoreductase activity, acting on diphenols and related substances as donorsCytochrome P450 1A1Homo sapiens (human)
flavonoid 3'-monooxygenase activityCytochrome P450 1A1Homo sapiens (human)
oxygen bindingCytochrome P450 1A1Homo sapiens (human)
enzyme bindingCytochrome P450 1A1Homo sapiens (human)
heme bindingCytochrome P450 1A1Homo sapiens (human)
Hsp70 protein bindingCytochrome P450 1A1Homo sapiens (human)
demethylase activityCytochrome P450 1A1Homo sapiens (human)
Hsp90 protein bindingCytochrome P450 1A1Homo sapiens (human)
aromatase activityCytochrome P450 1A1Homo sapiens (human)
vitamin D 24-hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
long-chain fatty acid omega-hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
hydroperoxy icosatetraenoate dehydratase activityCytochrome P450 1A1Homo sapiens (human)
long-chain fatty acid omega-1 hydroxylase activityCytochrome P450 1A1Homo sapiens (human)
monooxygenase activityCytochrome P450 1A2Homo sapiens (human)
iron ion bindingCytochrome P450 1A2Homo sapiens (human)
protein bindingCytochrome P450 1A2Homo sapiens (human)
electron transfer activityCytochrome P450 1A2Homo sapiens (human)
oxidoreductase activityCytochrome P450 1A2Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 1A2Homo sapiens (human)
enzyme bindingCytochrome P450 1A2Homo sapiens (human)
heme bindingCytochrome P450 1A2Homo sapiens (human)
demethylase activityCytochrome P450 1A2Homo sapiens (human)
caffeine oxidase activityCytochrome P450 1A2Homo sapiens (human)
aromatase activityCytochrome P450 1A2Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 1A2Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 1A2Homo sapiens (human)
hydroperoxy icosatetraenoate dehydratase activityCytochrome P450 1A2Homo sapiens (human)
monooxygenase activityCytochrome P450 2E1Homo sapiens (human)
iron ion bindingCytochrome P450 2E1Homo sapiens (human)
oxidoreductase activityCytochrome P450 2E1Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygenCytochrome P450 2E1Homo sapiens (human)
4-nitrophenol 2-monooxygenase activityCytochrome P450 2E1Homo sapiens (human)
oxygen bindingCytochrome P450 2E1Homo sapiens (human)
enzyme bindingCytochrome P450 2E1Homo sapiens (human)
heme bindingCytochrome P450 2E1Homo sapiens (human)
Hsp70 protein bindingCytochrome P450 2E1Homo sapiens (human)
Hsp90 protein bindingCytochrome P450 2E1Homo sapiens (human)
aromatase activityCytochrome P450 2E1Homo sapiens (human)
long-chain fatty acid omega-1 hydroxylase activityCytochrome P450 2E1Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2E1Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2E1Homo sapiens (human)
monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
steroid bindingCytochrome P450 3A4Homo sapiens (human)
iron ion bindingCytochrome P450 3A4Homo sapiens (human)
protein bindingCytochrome P450 3A4Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
retinoic acid 4-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
oxidoreductase activityCytochrome P450 3A4Homo sapiens (human)
oxygen bindingCytochrome P450 3A4Homo sapiens (human)
enzyme bindingCytochrome P450 3A4Homo sapiens (human)
heme bindingCytochrome P450 3A4Homo sapiens (human)
vitamin D3 25-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
caffeine oxidase activityCytochrome P450 3A4Homo sapiens (human)
quinine 3-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
testosterone 6-beta-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 8,9 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 11,12 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 14,15 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
aromatase activityCytochrome P450 3A4Homo sapiens (human)
vitamin D 24-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1,8-cineole 2-exo-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
monooxygenase activityCytochrome P450 2C8Homo sapiens (human)
iron ion bindingCytochrome P450 2C8Homo sapiens (human)
protein bindingCytochrome P450 2C8Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2C8Homo sapiens (human)
retinoic acid 4-hydroxylase activityCytochrome P450 2C8Homo sapiens (human)
caffeine oxidase activityCytochrome P450 2C8Homo sapiens (human)
aromatase activityCytochrome P450 2C8Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 2C8Homo sapiens (human)
heme bindingCytochrome P450 2C8Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2C8Homo sapiens (human)
monooxygenase activityCytochrome P450 2D6Homo sapiens (human)
iron ion bindingCytochrome P450 2D6Homo sapiens (human)
oxidoreductase activityCytochrome P450 2D6Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2D6Homo sapiens (human)
heme bindingCytochrome P450 2D6Homo sapiens (human)
anandamide 8,9 epoxidase activityCytochrome P450 2D6Homo sapiens (human)
anandamide 11,12 epoxidase activityCytochrome P450 2D6Homo sapiens (human)
anandamide 14,15 epoxidase activityCytochrome P450 2D6Homo sapiens (human)
iron ion bindingCytochrome P450 2A6Homo sapiens (human)
coumarin 7-hydroxylase activityCytochrome P450 2A6Homo sapiens (human)
enzyme bindingCytochrome P450 2A6Homo sapiens (human)
heme bindingCytochrome P450 2A6Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2A6Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2A6Homo sapiens (human)
monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
iron ion bindingCytochrome P450 2C9 Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2C9 Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 2C9 Homo sapiens (human)
arachidonic acid 14,15-epoxygenase activityCytochrome P450 2C9 Homo sapiens (human)
arachidonic acid 11,12-epoxygenase activityCytochrome P450 2C9 Homo sapiens (human)
oxidoreductase activityCytochrome P450 2C9 Homo sapiens (human)
(S)-limonene 6-monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
(S)-limonene 7-monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
caffeine oxidase activityCytochrome P450 2C9 Homo sapiens (human)
(R)-limonene 6-monooxygenase activityCytochrome P450 2C9 Homo sapiens (human)
aromatase activityCytochrome P450 2C9 Homo sapiens (human)
heme bindingCytochrome P450 2C9 Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2C9 Homo sapiens (human)
monooxygenase activityCytochrome P450 4B1Homo sapiens (human)
iron ion bindingCytochrome P450 4B1Homo sapiens (human)
oxygen bindingCytochrome P450 4B1Homo sapiens (human)
heme bindingCytochrome P450 4B1Homo sapiens (human)
aromatase activityCytochrome P450 4B1Homo sapiens (human)
heterocyclic compound bindingCytochrome P450 4B1Homo sapiens (human)
monooxygenase activityCytochrome P450 2B6Homo sapiens (human)
iron ion bindingCytochrome P450 2B6Homo sapiens (human)
testosterone 16-alpha-hydroxylase activityCytochrome P450 2B6Homo sapiens (human)
heme bindingCytochrome P450 2B6Homo sapiens (human)
testosterone 16-beta-hydroxylase activityCytochrome P450 2B6Homo sapiens (human)
anandamide 8,9 epoxidase activityCytochrome P450 2B6Homo sapiens (human)
anandamide 11,12 epoxidase activityCytochrome P450 2B6Homo sapiens (human)
anandamide 14,15 epoxidase activityCytochrome P450 2B6Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 2B6Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2B6Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2B6Homo sapiens (human)
monooxygenase activityCytochrome P450 3A5Homo sapiens (human)
iron ion bindingCytochrome P450 3A5Homo sapiens (human)
protein bindingCytochrome P450 3A5Homo sapiens (human)
retinoic acid 4-hydroxylase activityCytochrome P450 3A5Homo sapiens (human)
oxidoreductase activityCytochrome P450 3A5Homo sapiens (human)
oxygen bindingCytochrome P450 3A5Homo sapiens (human)
heme bindingCytochrome P450 3A5Homo sapiens (human)
aromatase activityCytochrome P450 3A5Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 3A5Homo sapiens (human)
testosterone 6-beta-hydroxylase activityCytochrome P450 3A5Homo sapiens (human)
iron ion bindingCytochrome P450 2A7Homo sapiens (human)
oxygen bindingCytochrome P450 2A7Homo sapiens (human)
aromatase activityCytochrome P450 2A7Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2A7Homo sapiens (human)
heme bindingCytochrome P450 2A7Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2A7Homo sapiens (human)
monooxygenase activityCytochrome P450 3A7Homo sapiens (human)
iron ion bindingCytochrome P450 3A7Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 3A7Homo sapiens (human)
retinoic acid 4-hydroxylase activityCytochrome P450 3A7Homo sapiens (human)
oxygen bindingCytochrome P450 3A7Homo sapiens (human)
heme bindingCytochrome P450 3A7Homo sapiens (human)
all-trans retinoic acid 18-hydroxylase activityCytochrome P450 3A7Homo sapiens (human)
aromatase activityCytochrome P450 3A7Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 3A7Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 3A7Homo sapiens (human)
testosterone 6-beta-hydroxylase activityCytochrome P450 3A7Homo sapiens (human)
monooxygenase activityCytochrome P450 2F1Homo sapiens (human)
iron ion bindingCytochrome P450 2F1Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2F1Homo sapiens (human)
oxygen bindingCytochrome P450 2F1Homo sapiens (human)
aromatase activityCytochrome P450 2F1Homo sapiens (human)
heme bindingCytochrome P450 2F1Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2F1Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingTranscriptional enhancer factor TEF-1Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificTranscriptional enhancer factor TEF-1Homo sapiens (human)
DNA bindingTranscriptional enhancer factor TEF-1Homo sapiens (human)
DNA-binding transcription factor activityTranscriptional enhancer factor TEF-1Homo sapiens (human)
protein bindingTranscriptional enhancer factor TEF-1Homo sapiens (human)
sequence-specific double-stranded DNA bindingTranscriptional enhancer factor TEF-1Homo sapiens (human)
monooxygenase activityCytochrome P450 2C18Homo sapiens (human)
iron ion bindingCytochrome P450 2C18Homo sapiens (human)
retinoic acid 4-hydroxylase activityCytochrome P450 2C18Homo sapiens (human)
oxygen bindingCytochrome P450 2C18Homo sapiens (human)
aromatase activityCytochrome P450 2C18Homo sapiens (human)
linoleic acid epoxygenase activityCytochrome P450 2C18Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2C18Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2C18Homo sapiens (human)
heme bindingCytochrome P450 2C18Homo sapiens (human)
monooxygenase activityCytochrome P450 2C19Homo sapiens (human)
iron ion bindingCytochrome P450 2C19Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 2C19Homo sapiens (human)
oxidoreductase activityCytochrome P450 2C19Homo sapiens (human)
(S)-limonene 6-monooxygenase activityCytochrome P450 2C19Homo sapiens (human)
(S)-limonene 7-monooxygenase activityCytochrome P450 2C19Homo sapiens (human)
oxygen bindingCytochrome P450 2C19Homo sapiens (human)
enzyme bindingCytochrome P450 2C19Homo sapiens (human)
heme bindingCytochrome P450 2C19Homo sapiens (human)
(R)-limonene 6-monooxygenase activityCytochrome P450 2C19Homo sapiens (human)
aromatase activityCytochrome P450 2C19Homo sapiens (human)
long-chain fatty acid omega-1 hydroxylase activityCytochrome P450 2C19Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2C19Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2C19Homo sapiens (human)
monooxygenase activityCytochrome P450 2J2Homo sapiens (human)
iron ion bindingCytochrome P450 2J2Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2J2Homo sapiens (human)
arachidonic acid 14,15-epoxygenase activityCytochrome P450 2J2Homo sapiens (human)
arachidonic acid 11,12-epoxygenase activityCytochrome P450 2J2Homo sapiens (human)
isomerase activityCytochrome P450 2J2Homo sapiens (human)
linoleic acid epoxygenase activityCytochrome P450 2J2Homo sapiens (human)
hydroperoxy icosatetraenoate isomerase activityCytochrome P450 2J2Homo sapiens (human)
arachidonic acid 5,6-epoxygenase activityCytochrome P450 2J2Homo sapiens (human)
heme bindingCytochrome P450 2J2Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2J2Homo sapiens (human)
monooxygenase activityCytochrome P450 4F2Homo sapiens (human)
iron ion bindingCytochrome P450 4F2Homo sapiens (human)
protein bindingCytochrome P450 4F2Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 4F2Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygenCytochrome P450 4F2Homo sapiens (human)
alkane 1-monooxygenase activityCytochrome P450 4F2Homo sapiens (human)
heme bindingCytochrome P450 4F2Homo sapiens (human)
leukotriene-B4 20-monooxygenase activityCytochrome P450 4F2Homo sapiens (human)
arachidonic acid omega-hydroxylase activityCytochrome P450 4F2Homo sapiens (human)
alpha-tocopherol omega-hydroxylase activityCytochrome P450 4F2Homo sapiens (human)
tocotrienol omega-hydroxylase activityCytochrome P450 4F2Homo sapiens (human)
aromatase activityCytochrome P450 4F2Homo sapiens (human)
20-hydroxy-leukotriene B4 omega oxidase activityCytochrome P450 4F2Homo sapiens (human)
20-aldehyde-leukotriene B4 20-monooxygenase activityCytochrome P450 4F2Homo sapiens (human)
long-chain fatty acid omega-hydroxylase activityCytochrome P450 4F2Homo sapiens (human)
monooxygenase activityCytochrome P450 4F8Homo sapiens (human)
iron ion bindingCytochrome P450 4F8Homo sapiens (human)
alkane 1-monooxygenase activityCytochrome P450 4F8Homo sapiens (human)
heme bindingCytochrome P450 4F8Homo sapiens (human)
aromatase activityCytochrome P450 4F8Homo sapiens (human)
monooxygenase activityCytochrome P450 4A11Homo sapiens (human)
iron ion bindingCytochrome P450 4A11Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 4A11Homo sapiens (human)
alkane 1-monooxygenase activityCytochrome P450 4A11Homo sapiens (human)
heme bindingCytochrome P450 4A11Homo sapiens (human)
leukotriene-B4 20-monooxygenase activityCytochrome P450 4A11Homo sapiens (human)
aromatase activityCytochrome P450 4A11Homo sapiens (human)
long-chain fatty acid omega-hydroxylase activityCytochrome P450 4A11Homo sapiens (human)
arachidonic acid monooxygenase activityCytochrome P450 4A11Homo sapiens (human)
monooxygenase activityCytochrome P450 4F3Homo sapiens (human)
iron ion bindingCytochrome P450 4F3Homo sapiens (human)
heme bindingCytochrome P450 4F3Homo sapiens (human)
leukotriene-B4 20-monooxygenase activityCytochrome P450 4F3Homo sapiens (human)
aromatase activityCytochrome P450 4F3Homo sapiens (human)
20-hydroxy-leukotriene B4 omega oxidase activityCytochrome P450 4F3Homo sapiens (human)
20-aldehyde-leukotriene B4 20-monooxygenase activityCytochrome P450 4F3Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificTranscriptional enhancer factor TEF-3Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificTranscriptional enhancer factor TEF-3Homo sapiens (human)
DNA-binding transcription factor activityTranscriptional enhancer factor TEF-3Homo sapiens (human)
protein bindingTranscriptional enhancer factor TEF-3Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingTranscriptional enhancer factor TEF-3Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificTranscriptional enhancer factor TEF-4Homo sapiens (human)
transcription coactivator bindingTranscriptional enhancer factor TEF-4Homo sapiens (human)
DNA-binding transcription factor activityTranscriptional enhancer factor TEF-4Homo sapiens (human)
protein bindingTranscriptional enhancer factor TEF-4Homo sapiens (human)
disordered domain specific bindingTranscriptional enhancer factor TEF-4Homo sapiens (human)
sequence-specific double-stranded DNA bindingTranscriptional enhancer factor TEF-4Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingTranscriptional enhancer factor TEF-4Homo sapiens (human)
monooxygenase activityCytochrome P450 1B1Homo sapiens (human)
iron ion bindingCytochrome P450 1B1Homo sapiens (human)
protein bindingCytochrome P450 1B1Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 1B1Homo sapiens (human)
heme bindingCytochrome P450 1B1Homo sapiens (human)
aromatase activityCytochrome P450 1B1Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 1B1Homo sapiens (human)
hydroperoxy icosatetraenoate dehydratase activityCytochrome P450 1B1Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygenCytochrome P450 1B1Homo sapiens (human)
monooxygenase activityCytochrome P450 2A13Homo sapiens (human)
iron ion bindingCytochrome P450 2A13Homo sapiens (human)
coumarin 7-hydroxylase activityCytochrome P450 2A13Homo sapiens (human)
heme bindingCytochrome P450 2A13Homo sapiens (human)
aromatase activityCytochrome P450 2A13Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2A13Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2A13Homo sapiens (human)
arachidonic acid omega-hydroxylase activityCytochrome P450 4A22Homo sapiens (human)
iron ion bindingCytochrome P450 4A22Homo sapiens (human)
heme bindingCytochrome P450 4A22Homo sapiens (human)
long-chain fatty acid omega-hydroxylase activityCytochrome P450 4A22Homo sapiens (human)
16-hydroxypalmitate dehydrogenase activityCytochrome P450 4A22Homo sapiens (human)
medium-chain fatty acid omega-hydroxylase activityCytochrome P450 4A22Homo sapiens (human)
arachidonic acid monooxygenase activityCytochrome P450 4A22Homo sapiens (human)
alkane 1-monooxygenase activityCytochrome P450 4A22Homo sapiens (human)
iron ion bindingVitamin D 25-hydroxylaseHomo sapiens (human)
heme bindingVitamin D 25-hydroxylaseHomo sapiens (human)
vitamin D3 25-hydroxylase activityVitamin D 25-hydroxylaseHomo sapiens (human)
protein homodimerization activityVitamin D 25-hydroxylaseHomo sapiens (human)
D3 vitamins bindingVitamin D 25-hydroxylaseHomo sapiens (human)
steroid hydroxylase activityVitamin D 25-hydroxylaseHomo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenVitamin D 25-hydroxylaseHomo sapiens (human)
monooxygenase activityCytochrome P450 2U1Homo sapiens (human)
iron ion bindingCytochrome P450 2U1Homo sapiens (human)
arachidonic acid omega-hydroxylase activityCytochrome P450 2U1Homo sapiens (human)
long-chain fatty acid omega-hydroxylase activityCytochrome P450 2U1Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 2U1Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2U1Homo sapiens (human)
heme bindingCytochrome P450 2U1Homo sapiens (human)
retinoic acid bindingCytochrome P450 2W1Homo sapiens (human)
monooxygenase activityCytochrome P450 2W1Homo sapiens (human)
all-trans retinal bindingCytochrome P450 2W1Homo sapiens (human)
iron ion bindingCytochrome P450 2W1Homo sapiens (human)
retinoic acid 4-hydroxylase activityCytochrome P450 2W1Homo sapiens (human)
all-trans-retinol bindingCytochrome P450 2W1Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2W1Homo sapiens (human)
heme bindingCytochrome P450 2W1Homo sapiens (human)
monooxygenase activityCytochrome P450 2S1Homo sapiens (human)
thromboxane-A synthase activityCytochrome P450 2S1Homo sapiens (human)
iron ion bindingCytochrome P450 2S1Homo sapiens (human)
protein bindingCytochrome P450 2S1Homo sapiens (human)
retinoic acid 4-hydroxylase activityCytochrome P450 2S1Homo sapiens (human)
hydro-lyase activityCytochrome P450 2S1Homo sapiens (human)
12-hydroxyheptadecatrienoic acid synthase activityCytochrome P450 2S1Homo sapiens (human)
hydroperoxy icosatetraenoate dehydratase activityCytochrome P450 2S1Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2S1Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2S1Homo sapiens (human)
heme bindingCytochrome P450 2S1Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificTranscriptional enhancer factor TEF-5Homo sapiens (human)
DNA-binding transcription factor activityTranscriptional enhancer factor TEF-5Homo sapiens (human)
protein bindingTranscriptional enhancer factor TEF-5Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingTranscriptional enhancer factor TEF-5Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingTranscriptional enhancer factor TEF-5Homo sapiens (human)
monooxygenase activityCytochrome P450 3A43 Homo sapiens (human)
iron ion bindingCytochrome P450 3A43 Homo sapiens (human)
heme bindingCytochrome P450 3A43 Homo sapiens (human)
aromatase activityCytochrome P450 3A43 Homo sapiens (human)
testosterone 6-beta-hydroxylase activityCytochrome P450 3A43 Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 3A43 Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (19)

Processvia Protein(s)Taxonomy
mitochondrial inner membraneCytochrome P450 1A1Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 1A1Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A1Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 1A2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A2Homo sapiens (human)
mitochondrial inner membraneCytochrome P450 2E1Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2E1Homo sapiens (human)
cytoplasmCytochrome P450 2E1Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2E1Homo sapiens (human)
cytoplasmCytochrome P450 3A4Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 3A4Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 3A4Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2C8Homo sapiens (human)
plasma membraneCytochrome P450 2C8Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C8Homo sapiens (human)
cytoplasmCytochrome P450 2C8Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C8Homo sapiens (human)
mitochondrionCytochrome P450 2D6Homo sapiens (human)
endoplasmic reticulumCytochrome P450 2D6Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2D6Homo sapiens (human)
cytoplasmCytochrome P450 2D6Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2D6Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2A6Homo sapiens (human)
cytoplasmic microtubuleCytochrome P450 2A6Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2A6Homo sapiens (human)
cytoplasmCytochrome P450 2A6Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2C9 Homo sapiens (human)
plasma membraneCytochrome P450 2C9 Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C9 Homo sapiens (human)
cytoplasmCytochrome P450 2C9 Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C9 Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 4B1Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
endoplasmic reticulum membraneCytochrome P450 2B6Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2B6Homo sapiens (human)
cytoplasmCytochrome P450 2B6Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 3A5Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 3A5Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2A7Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2A7Homo sapiens (human)
cytoplasmCytochrome P450 2A7Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 3A7Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2F1Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2F1Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2F1Homo sapiens (human)
cytoplasmCytochrome P450 2F1Homo sapiens (human)
nucleusTranscriptional enhancer factor TEF-1Homo sapiens (human)
nucleoplasmTranscriptional enhancer factor TEF-1Homo sapiens (human)
TEAD-YAP complexTranscriptional enhancer factor TEF-1Homo sapiens (human)
chromatinTranscriptional enhancer factor TEF-1Homo sapiens (human)
transcription regulator complexTranscriptional enhancer factor TEF-1Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2C18Homo sapiens (human)
plasma membraneCytochrome P450 2C18Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C18Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C18Homo sapiens (human)
cytoplasmCytochrome P450 2C18Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2C19Homo sapiens (human)
plasma membraneCytochrome P450 2C19Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C19Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2C19Homo sapiens (human)
cytoplasmCytochrome P450 2C19Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2J2Homo sapiens (human)
extracellular exosomeCytochrome P450 2J2Homo sapiens (human)
cytoplasmCytochrome P450 2J2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2J2Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
cytoplasmCytochrome P450 4F2Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 4F2Homo sapiens (human)
apical plasma membraneCytochrome P450 4F2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 4F2Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 4F8Homo sapiens (human)
cytoplasmCytochrome P450 4A11Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 4A11Homo sapiens (human)
apical plasma membraneCytochrome P450 4A11Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 4A11Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 4A11Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 4F3Homo sapiens (human)
nucleusTranscriptional enhancer factor TEF-3Homo sapiens (human)
nucleoplasmTranscriptional enhancer factor TEF-3Homo sapiens (human)
cytoplasmTranscriptional enhancer factor TEF-3Homo sapiens (human)
chromatinTranscriptional enhancer factor TEF-3Homo sapiens (human)
transcription regulator complexTranscriptional enhancer factor TEF-3Homo sapiens (human)
nucleusTranscriptional enhancer factor TEF-4Homo sapiens (human)
nucleoplasmTranscriptional enhancer factor TEF-4Homo sapiens (human)
cytosolTranscriptional enhancer factor TEF-4Homo sapiens (human)
intracellular membrane-bounded organelleTranscriptional enhancer factor TEF-4Homo sapiens (human)
chromatinTranscriptional enhancer factor TEF-4Homo sapiens (human)
TEAD-YAP complexTranscriptional enhancer factor TEF-4Homo sapiens (human)
transcription regulator complexTranscriptional enhancer factor TEF-4Homo sapiens (human)
mitochondrionCytochrome P450 1B1Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 1B1Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1B1Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2A13Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2A13Homo sapiens (human)
cytoplasmCytochrome P450 2A13Homo sapiens (human)
extracellular spaceCytochrome P450 4A22Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 4A22Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 4A22Homo sapiens (human)
endoplasmic reticulum membraneVitamin D 25-hydroxylaseHomo sapiens (human)
intracellular membrane-bounded organelleVitamin D 25-hydroxylaseHomo sapiens (human)
cytoplasmVitamin D 25-hydroxylaseHomo sapiens (human)
mitochondrial inner membraneCytochrome P450 2U1Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2U1Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2U1Homo sapiens (human)
cytoplasmCytochrome P450 2U1Homo sapiens (human)
endoplasmic reticulum lumenCytochrome P450 2W1Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2W1Homo sapiens (human)
plasma membraneCytochrome P450 2W1Homo sapiens (human)
cell surfaceCytochrome P450 2W1Homo sapiens (human)
cytoplasmCytochrome P450 2W1Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2W1Homo sapiens (human)
endoplasmic reticulumCytochrome P450 2S1Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 2S1Homo sapiens (human)
cytoplasmCytochrome P450 2S1Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2S1Homo sapiens (human)
nucleoplasmTranscriptional enhancer factor TEF-5Homo sapiens (human)
chromatinTranscriptional enhancer factor TEF-5Homo sapiens (human)
transcription regulator complexTranscriptional enhancer factor TEF-5Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 3A43 Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (56)

Assay IDTitleYearJournalArticle
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1624082Binding affinity to TEAD1 (194 to 411 residues) (unknown origin) by NMR analysis2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID1624083Inhibition of Gal4-fused TEAD1 (unknown origin) interaction with YAP expressed in human HeLa cells assessed as basal transcriptional activity level up to 100 uM after 6 hrs by nanoluciferase reporter gene assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID497005Antimicrobial activity against Pneumocystis carinii2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID1624095Inhibition of TEAD in rat VSMC assessed as reduction in THBS m-RNA expression at 60 uM by RT-qPCR analysis2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID1624096Inhibition of TEAD in rat VSMC assessed as reduction in MAYDM m-RNA expression at 60 uM by RT-qPCR analysis2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID1624098Inhibition of TEAD in rat VSMC assessed as reduction in CCN1 m-RNA expression at 60 uM by RT-qPCR analysis2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID1624099Inhibition of PGK1 m-RNA expression in rat VSMC at 60 uM by RT-qPCR analysis2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID496818Antimicrobial activity against Trypanosoma brucei brucei2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID496832Antimicrobial activity against Trypanosoma brucei rhodesiense2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID71694Antagonist activity against Gamma-aminobutyric acid A (GABA-A) receptor2000Journal of medicinal chemistry, Apr-20, Volume: 43, Issue:8
GABA-Activated ligand gated ion channels: medicinal chemistry and molecular biology.
AID1624087Inhibition of Gal4-fused TEAD1 (unknown origin) interaction with YAP expressed in human HeLa cells assessed as basal transcriptional activity level after 6 hrs by nanoluciferase reporter gene assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID1624090Inhibition of Gal4-fused TEAD4 (unknown origin) interaction with YAP expressed in human HeLa cells assessed as basal transcriptional activity level after 6 hrs by nanoluciferase reporter gene assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID1624105Antimigratory activity in human VSMC incubated for overnight followed by media replacement and measured every hour for 24 hrs by phase contrast microscopic analysis2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID496826Antimicrobial activity against Entamoeba histolytica2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID1624109Inhibition of TEAD in rat VSMC assessed as reduction in CCN1 protein expression up to 60 uM by Western blot analysis2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID1624107Inhibition of Gal4 expression in human HeLa cells assessed as basal transcriptional activity level at 100 uM after 6 hrs by nanoluciferase reporter gene assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID1624093Inhibition of TEAD (unknown origin) expressed in rat VSMC after 6 hrs by nanoluciferase reporter gene assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID496829Antimicrobial activity against Leishmania infantum2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID1624067Inhibition of TEAD in rat VSMC assessed as reduction in CTGF m-RNA expression incubated for 2 hrs followed by compound wash out and re-treatment for 4 hrs by by NanoGlo assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID496820Antimicrobial activity against Trypanosoma brucei2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID1624066Inhibition of TEAD in rat VSMC assessed as reduction in CCN1 m-RNA expression incubated for 2 hrs followed by compound wash out and re-treatment for 4 hrs by by NanoGlo assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID496831Antimicrobial activity against Cryptosporidium parvum2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID1624103Inhibition of TEAD in rat VSMC assessed as reduction in CTGF m-RNA expression at 60 uM by RT-qPCR analysis2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID1624065Inhibition of TEAD in human HeLa cells assessed as reduction in CTGF m-RNA expression incubated for 2 hrs followed by compound wash out and re-treatment for 4 hrs by by NanoGlo assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID1624106Antiproliferative activity against human MCF7 assessed as reduction in EdU incorporation up to 40 uM after 24 hrs by Hoechst 33342 staining-based fluorescence assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID1624110Antiproliferative activity against rat VSMC assessed as reduction in EdU incorporation after 18 hrs by Hoechst 33342 staining-based fluorescence assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID496825Antimicrobial activity against Leishmania mexicana2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID1624089Inhibition of Gal4-fused TEAD3 (unknown origin) interaction with YAP expressed in human HeLa cells assessed as basal transcriptional activity level after 6 hrs by nanoluciferase reporter gene assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID496817Antimicrobial activity against Trypanosoma cruzi2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID1624100Inhibition of TBP m-RNA expression in rat VSMC at 60 uM by RT-qPCR analysis2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID1624081Binding affinity to TEAD1 (194 to 411 residues) (unknown origin) by ITC assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID1624102Inhibition of 36B4 m-RNA expression in rat VSMC at 60 uM by RT-qPCR analysis2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID1624088Inhibition of Gal4-fused TEAD2 (unknown origin) interaction with YAP expressed in human HeLa cells assessed as basal transcriptional activity level after 6 hrs by nanoluciferase reporter gene assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID1624104Antiproliferative activity against human VSMC assessed as reduction in EdU incorporation after 18 hrs by Hoechst 33342 staining-based fluorescence assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID1624085Inhibition of Gal4-fused TEAD3 (unknown origin) interaction with YAP expressed in human HeLa cells assessed as basal transcriptional activity level up to 100 uM after 6 hrs by nanoluciferase reporter gene assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID1624078Cytotoxicity against human HeLa cells assessed as reduction in cell viability by measuring ethidium homodimer-1 uptake at 20 uM preincubated for 10 mins followed by ethidium homodimer-1 addition measured after 10 mins by fluorescence assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID496823Antimicrobial activity against Trichomonas vaginalis2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID1624073Antiproliferative activity against human HeLa cells assessed as reduction in EdU incorporation after 24 hrs by Hoechst 33342 staining-based fluorescence assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID1624097Inhibition of TEAD in rat VSMC assessed as reduction in MYOC m-RNA expression at 60 uM by RT-qPCR analysis2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID1624101Inhibition of GAPDH m-RNA expression in rat VSMC at 60 uM by RT-qPCR analysis2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID1624092Antimigratory activity in human HeLa cells at 40 to 80 uM incubated for overnight followed by media replacement and measured every hour for 24 hrs by phase contrast microscopic analysis2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID1624074Antimigratory activity in rat VSMC incubated for overnight followed by media replacement and measured every hour for 24 hrs by phase contrast microscopic analysis2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID1624094Inhibition of TEAD in rat VSMC assessed as reduction in PAI1 m-RNA expression at 60 uM by RT-qPCR analysis2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID496828Antimicrobial activity against Leishmania donovani2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID496819Antimicrobial activity against Plasmodium falciparum2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID1624108Inhibition of SRF (unknown origin) mediated VP16 transcription expressed in human HeLa cells assessed as basal transcriptional activity level up to 100 uM after 6 hrs by nanoluciferase reporter gene assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID496830Antimicrobial activity against Leishmania major2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID496827Antimicrobial activity against Leishmania amazonensis2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID1624091Inhibition of TNT1 m-RNA expression in human HeLa cells incubated for 2 hrs followed by compound wash out and re-treatment for 4 hrs by by NanoGlo assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID496824Antimicrobial activity against Toxoplasma gondii2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID496821Antimicrobial activity against Leishmania2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
AID1624086Inhibition of Gal4-fused TEAD4 (unknown origin) interaction with YAP expressed in human HeLa cells assessed as basal transcriptional activity level up to 100 uM after 6 hrs by nanoluciferase reporter gene assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID1624077Inhibition of TEAD (unknown origin) expressed in human HeLa cells after 6 hrs by nanoluciferase reporter gene assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID1624064Inhibition of TEAD in human HeLa cells assessed as reduction in CCN1 m-RNA expression incubated for 2 hrs followed by compound wash out and re-treatment for 4 hrs by by NanoGlo assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID1624084Inhibition of Gal4-fused TEAD2 (unknown origin) interaction with YAP expressed in human HeLa cells assessed as basal transcriptional activity level up to 100 uM after 6 hrs by nanoluciferase reporter gene assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (79)

TimeframeStudies, This Drug (%)All Drugs %
pre-199031 (39.24)18.7374
1990's22 (27.85)18.2507
2000's17 (21.52)29.6817
2010's9 (11.39)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.79 (24.57)
Research Supply Index4.83 (2.92)
Research Growth Index4.26 (4.65)
Search Engine Demand Index45.55 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (33.79)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials13 (11.71%)5.53%
Reviews8 (7.21%)6.00%
Case Studies2 (1.80%)4.05%
Observational0 (0.00%)0.25%
Other88 (79.28%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]